Kleinman PD, Griner PFStudies of the epidemiology of anticoagulant-drug interactions. Arch Intern Med1970;126:522-3.
2.
Walters MBThe relationship between thyroid function and anticoagulant therapy . Am J Cardiol1963;11:112-4.
3.
Simone JV, Abildgaard CF, Schulman I.Blood coagulation in thyroid dysfunction. New Engl J Med1965;273:1057-61.
4.
Schrogie JJ, Solomon HMThe anticoagulant response to bishydroxycoumarin. II. The effect of D-thyroxine, clofibrate, and norethandrolone. Clin Pharmacol Ther1967;8:70-7.
5.
Lowenthal J. , Fisher LMThe effect of thyroid function on prothrombin time response to Warfarin in rats. Experientia1957;13:253-4.
6.
Best MM, Duncan CHComparative effects of thyroxine analogues as hypercholesteremic agents . Circulation1961;24:58-67.
7.
Owens JC, Neely WB, Owen WREffect of sodium dextrothyroxine in patients receiving anticoagutants. N Engl J Med1962;266:76-9.
8.
Solomon HM, Schrogie JJChange in receptor site affinity: a proposed explanation for the potentiating effect of D-thyroxine on the anticoagulant response to Warfarin. Clin Pharmacol Ther1967;8:797-9.
9.
Loeligeir EA , van der Esch B., Mattern MJ, et al. Biological disappearance rate of prothrombin, factors VII, IX and X. Thromb Diath Haemorrh1964;10:266-7.
Weintraub M. , Breckenridge RT, Griner PFThe effects of dextrothyroxine on the kinetics of prothrombin activity: proposed mechanism of the potentiation of Warfarin of D-thyroxine. J Lab Clin Med1973;8a:273-9.
12.
Starr P.Comparative clinical and biochemical effects of the Dextro and Levo-isomers of thyroxine. Arch Intern Med1958;101:723-30.